SETBP1 and myelodysplastic syndrome: In line with the GSE58831 cohort, the data of our own center showed SETBP1 mRNA was elevated in MDS patients with blasts ≥ 5% (Fig. 5A) compared with healthy donors, and parallel with disease risk (Fig. 5B).